Clinical Trial

The Pilot Study of Medical Device-Neuclare for Patients With Idiopathic Normal Pressure Hydrocephalus (iNPH)

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 30, 2024 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This clinical trial aims to explore the effectiveness and safety of gait improvemen of Neuclare, a science medical device, for patients with Idiopathic Normal Pressure Hydrocephalus (iNPH) Through methods such as Timed Up \& Go Test (TUG), 10m gait , iNPH grading scale), etc, gait improvement before and after using Neuclare will be evaluated.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-06-23; most recent amendment 2024-12-26.
Status change: Not Yet Recruiting → Recruiting 2024-08-06
Trial Details
NCT Number NCT06478979
Lead Sponsor Deepsonbio
Conditions Idiopathic Normal Pressure Hydrocephalus (iNPH)
Enrollment 20 participants
Start Date 2024-07-22
Primary Completion 2025-12-01 (estimated)
Study Completion 2026-01-01 (estimated)
Updated on ClinicalTrials.gov 2024-12-30